Skip to content
MedGenome – Leading Genetics Diagnostics Lab in India
MedGenome – Leading Genetics Diagnostics Lab in India
Menu
About Us
Tests & Services
Claria
Non-invasive prenatal screening test (NIPT)
Carrier Screening
PGT-A/PGT-M, S
Recurrent Pregnancy Loss Test
Molecular Cytogenetics
Rhesus D Track
More...
Actia
Molecular Test
FSHD1
Rapid Exome
ExomeMax
Clinical Exome
Chromosomal Microarray
Whole Exome
Trio Exome
Polygenic Risk Score for CAD
Panels
Neuro Genetics
Nephro Genetics
Cardio Genetics
Endocrine Genetics
Metabolic Genetics
Ocular Genetics
ENT Genetics
More...
Prima
Molecular Test
Molecular testing for Solid Tumors
Molecular testing for Hematological Malignancies
Panels
LungTrack Advance
Tumor Mutation Burden
TumorTrack Advance
BRCA1 and BRCA2 Gene Test
HLA Typing
Liquid Biopsy
clonoSEQ® NGS MRD
Thalassemia Mutation Testing
Immunophenotyping by Flowcytometry
Thyrotrack
More...
Micra
COVID-19 (SARS-CoV2) RT-PCR Test
SPIT SEQ
TB Diagnostics Solution
Gastrointestinal Infections
Syndrome Evaluation System (SES)
SES for CNS Infections
SES for Systemic Infections
SES for Eye Infections
More...
Immucare
RESEARCH SERVICES
Resources
Blog
Brochures
Publications
Patient Stories
Videos
Insights
Coronary Artery Disease
BRCA1 and BRCA2
NIPT
Genetic Counseling
Rare Diseases
HLA Typing
Genetic Insights
DNA Insights
Request Test Details
Schedule Genetic Counselling
Choose the region
Region:
Takeda launches mobile app for management of genetic diseases – Bangalore Times
Related Articles
All you need to know about Preimplantation Genetic Testing (PGT)
Empowering Genetic Testing: The Role of BRCA1 and BRCA2 Testing in Understanding Cancer
Empowering thalassemia patients to take control over health
MedGenome, backed by Sequoia Capital, acquires Delhi-NCR based Prognosis Laboratories
Toll free number: 1800 103 3691
diagnostics@medgenome.com
Enquire Now
Call Now